First-pass extracted concept

immune checkpoint inhibitor immunotherapy

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Aliases

immunotherapy

Evidence Snippets

The advent of immunotherapy has significantly improved outcomes for lung cancer patients in both early and advanced stages.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1adverse event associationsupports2026Source 1DOI PubMed

Immunotherapy is frequently associated with endocrine toxicities.

Claim 2clinical outcomesupports2026Source 1DOI PubMed

Immunotherapy has significantly improved outcomes for lung cancer patients in both early and advanced stages.

Claim 3clinical relevancesupports2026Source 1DOI PubMed

Diagnosing and treating obstructive sleep apnea in lung cancer patients undergoing immunotherapy could help optimize therapeutic efficacy and overall health.

Claim 4interaction hypothesissupports2026Source 1DOI PubMed

Endocrine toxicities associated with immunotherapy may overlap or interact with metabolic alterations observed in obstructive sleep apnea.